News Updates
Stem Cells in Orthopedic Rheumatology: Where Clinical Signals Are Strongest
Stem-cell therapies in orthopedic rheumatology offer dual promise: immunomodulation and tissue repair. This editorial reviews 2023-2025 evidence across key rheumatic diseases, identifying where clinical signals are strongest. Mesenchymal stromal/stem cells (MSCs) show encouraging immunologic and symptomatic benefits in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), particularly lupus nephritis, with acceptable short-term safety. However, trial heterogeneity in MSC source, dose, and manufacturing limits reproducibility.
Source: ResearchGate
Current and Emerging Therapies for Knee Osteoarthritis: From Conventional Approaches to Machine Learning and Stem Cell Innovations
Osteoarthritis is characterized by cartilage degradation and joint distortion. The most prevalent version of osteoarthritis, knee osteoarthritis (KOA), affects millions, acting as a leading cause of disability. With the average life expectancy continuing to grow, the global burden of KOA is expected to increase. KOA involves chronic pain that limits function and adversely impacts patients’ quality of life.
Source: ScienceDirect
Application of Stem Cells in Degenerative Orthopedic Diseases
Degenerative orthopedic diseases, traditionally viewed as inevitable “wear-and-tear” processes, are now being reimagined as dynamic failures of tissue homeostasis orchestrated by a complex interplay of chronic inflammation and metabolic exhaustion.
Source: Frontiers
Current Status and Future Prospects of Functionalized Mesenchymal Stem Cells for the Treatment of Spinal Cord Injury
Spinal cord injury (SCI) represents a critical neurological disorder characterized by intricate pathophysiological processes. The hostile local environment induced by secondary damage markedly hinders intrinsic neural repair, and currently available therapies exhibit limited clinical effectiveness. Recently, mesenchymal stem cells (MSCs) have attracted considerable attention due to their paracrine-mediated therapeutic properties, including immunoregulatory effects, neurotrophic factor secretion, and promotion of angiogenesis.
Source: ScienceDirect
Long-Term Safety and Clinical Outcomes from A Single-Site Phase 1 Study of Neural Stem Cell Transplantation for Chronic Cervical Spinal Cord Injury
Neural stem cell transplantation offers a promising avenue for spinal cord injury (SCI) repair, but demonstrating safety and feasibility in human populations remains a critical step. In this phase 1 trial, we investigate the long-term outcomes of cervical spinal cord implantation of NSI-566, a human spinal cord-derived neural stem cell line. With prospective data collection over 60 months, we assess adverse events, functional outcomes, and neurophysiological measures in a small cohort (N = 3) of chronic AIS-A SCI patients.
Source: ScienceDirect
Clinical Application of Mesenchymal Stem Cells in Orthopaedics and Traumatology in Daily Practice
Mesenchymal stem cells (MSCs) have been widely used in preclinical and clinical orthopaedic and traumatology studies (1). Compared to other cell therapies, MSCs have a variety of characteristics, such as a lower risk of teratoma than pluripotent stem cells, stemness potency, targeted therapy through chemo-attraction, ease of isolation, and rapid proliferation (2). However, the application from bench to bedside requires a standardized procedure for its administration (1).
Source: ScienceDirect
Current and Emerging Therapies for Knee Osteoarthritis: From Conventional Approaches to Machine Learning and Stem Cell Innovations
Osteoarthritis is characterized by cartilage degradation and joint distortion. The most prevalent version of osteoarthritis, knee osteoarthritis (KOA), affects millions, acting as a leading cause of disability.
Source: ScienceDirect
